Rapid Communication
Copyright ©2008 The WJG Press and Baishideng. All rights reserved.
World J Gastroenterol. Oct 28, 2008; 14(40): 6237-6243
Published online Oct 28, 2008. doi: 10.3748/wjg.14.6237
Effect of a fermented milk containing Bifidobacterium lactis DN-173010 on Chinese constipated women
Yue-Xin Yang, Mei He, Gang Hu, Jie Wei, Philippe Pages, Xian-Hua Yang, Sophie Bourdu-Naturel
Yue-Xin Yang, Mei He, Institute of Nutrition and Food Safety, China CDC, No. 29, Nanwei Road, Xuanwu District, Beijing 100050, China
Gang Hu, Jie Wei, Beijing Hospital, No. 1 Dahua Avenue, Dongdan, East District, Beijing 100730, China
Philippe Pages, Xian-Hua Yang, Danone Dairy Shanghai R&D Center, RM102, Building 12, 1387 Zhangdong Rd, Shanghai 201203, China
Sophie Bourdu-Naturel, Danone Research, RD128, 91767 Palaiseau, France
Author contributions: Yang YX designed the study; He M analyzed the data and wrote the paper; Wei J and Hu G performed the study; Pages P contributed to the study design; Yang XH coordinated the study and contributed paper writing; Bourdu-Naturel S contributed paper writing and data analysis.
Supported by Danone (Shanghai) Consulting Co. Ltd; 115 national science and technology program
Correspondence to: Sophie Bourdu-Naturel, Danone Research, RD128, 91767 Palaiseau, France. sophie.bourdu-naturel@danone.com
Telephone: +33-169-357249 Fax: +33-169-357696
Received: July 4, 2008
Revised: September 25, 2008
Accepted: October 2, 2008
Published online: October 28, 2008
Abstract

AIM: To investigate the effect of a fermented milk containing Bifidobacterium lactis DN-173010 and yogurt strains (BIO®) on adult women with constipation in Beijing.

METHODS: A total of 135 adult females with constipation were randomly allocated to consume for 2 wk either 100 g of the test fermented milk or 100 g of an acidified milk containing non-living bacteria (control). Stool frequency, defecation condition scores, stool consistency and food intake were recorded at baseline and after 1 and 2 wk in an intention-to-treat population of 126 subjects. In parallel, safety evaluation parameters were performed.

RESULTS: At baseline, no differences were found between groups. Following consumption of test product, stool frequency was significantly increased after 1 wk (3.5 ± 1.5 vs 2.4 ± 0.6, P < 0.01) and 2 wk (4.1 ± 1.7 vs 2.4 ± 0.6, P < 0.01), vs baseline. Similarly, after 1 and 2 wk, of test product consumption, defecation condition (1.1 ± 0.9 vs 1.9 ± 1.2, P < 0.01 and 0.8 ± 1.0 vs 1.9 ± 1.2, P < 0.01, respectively) and stool consistency (1.0 ± 0.8 vs 1.5 ± 1.1, P < 0.01 and 0.6 ± 0.8 vs 1.5 ± 1.1, P < 0.01, respectively) were significantly improved. Compared with the control group, stool frequency was also significantly increased (3.5 ± 1.5 vs 2.5 ± 0.9, P < 0.01 and 4.1 ± 1.7 vs 2.6 ± 1.0, P < 0.01, respectively), and defecation condition (1.1 ± 0.9 vs 1.6 ± 1.1, P < 0.01 and 0.8 ± 1.0 vs 1.6 ± 1.1, P < 0.01, respectively) and stool consistency (1.0 ± 0.8 vs 1.4 ± 1.0, P < 0.05 and 0.6 ± 0.8 vs 1.3 ± 1.0, P < 0.01, respectively) significantly decreased after 1 and 2 wk of product consumption. During the same period, food intake did not change between the two groups, and safety parameters of the subjects were within normal ranges.

CONCLUSION: This study suggests a beneficial effect of a fermented milk containing B. lactis DN-173010 on stool frequency, defecation condition and stool consistency in adult women with constipation constipated women after 1 and 2 wk of consumption.

Keywords: Probiotic; Bifidobacterium lactis DN-173010; Fermented milk; Constipation; Stool frequency; Stool consistency